head
Scanning the brain for PTSD
Submitted by Anonymous on Sun, 2010-01-24 21:36A study published this week reports that a machine known as magnetoencephalography can correctly identify PTSD 90% of the time. Researchers at the VA in Minneapolis, Minnesota used technology that has been studied for years: imaging the activity of the brain using magnetic sensors. Wikipedia has a nice article about the technique, but it should be noted that the Wikipedia article about Magneto the comic book character is probably longer.»
- Read more
- 11137 reads
Dr. Emanuel is busy
Submitted by Anonymous on Fri, 2009-07-17 10:16So I had the bright idea to call Dr. Ezekiel Emanuel. Part of the power trio of Emanuel brothers this seems to be a guy who can get things done in Washington. He has met with Barack Obama to advise him on health care reform written books on the subject etc. I thought I could appeal to him about this JNCI issue. Basically I think the journal of our National Cancer Institute should be free for all American taxpayers to access. We paid for that research and writing and we should get to read it for free. It would be like NOAA making you pay to get the weather data.
- Read more
- 916 reads
Small D.O. med school prof puts the smackdown on JAMA!
Submitted by Anonymous on Fri, 2009-03-13 23:13- Antidepressant
- author
- BMJ
- British Medical Journal
- Catherine D. DeAngelis
- Clinical trial
- deputy editor
- editor in chief
- Escitalopram
- executive
- Forest Laboratories
- Harrogate
- head
- Health
- http://www.bmj.com/cgi/eletters/338/feb05_1/b463#208503
- http://www.westernu.edu/xp/edu/comp/faculty-leo.xml
- JAMA
- JAMA Catherine DeAngelis
- Jonathan Leo
- Jonathan Simons
- Journal of the American Medical Association
- Lexapro
- Lincoln
- Lincoln Memorial University
- Medical journals
- Medicine
- Person Career
- Phil Fontanarosa
- Professor
- Quotation
- reporter
- Science
- spokeswoman
- Technology
- Technology
- Tennessee
- the British Medical Journal
- The Wall Street Journal
- Wall Street Journal
- XML
WSJ today reports a fascinating piece that exposes the dark underbelly of clinical research. "Jonathan Leo a professor of neuro-anatomy at tiny Lincoln Memorial University in Harrogate Tenn. posted a letter on the Web site of the British Medical Journal this month criticizing a study that appeared in JAMA last spring. The study concerned the use of the anti-depressant Lexapro in stroke patients.
- Read more
- 1556 reads
Hairspray link to birth defect reported
Submitted by Anonymous on Mon, 2008-11-24 10:12- Andreas Kortenkamp
- Andrology
- Barcelona
- chemical
- chemicals
- Congenital disorders
- Edinburgh
- Edinburgh University
- Folic acid
- head
- Human reproduction
- Hypospadias
- Imperial College
- London
- Male reproductive system
- Medicine
- Other
- Paul Elliott
- Penis
- Person Career
- Pharmacy University of London
- Phthalate
- plastics
- Pregnancy
- printing
- Professor
- Richard Sharpe
- University College Cork
- University of London
- Urology
Hypospadias is considered as the most common birth defect of a male genitalia in which the penile meatus is not at the tip of the penis. The meatus is the term for opening the penis through which urine usually exits the bladder. This deficiency can be found in 1 in 125 boys born in the US. The name "hypospadias" comes from the Greek word (hypo under and spadias rent). It refers to the position of the opening through which the child urinates.
- Read more
- 1303 reads
Magnetic field appears to rouse coma patient
Submitted by Anonymous on Sat, 2008-10-18 15:26- Biology
- CHICAGO
- German University
- German University of Gottingen
- head
- Illinois
- Josh Villa
- Laurie McAndrews
- Medicine
- Migraine
- Neurophysiology
- Neuropsychology
- Neurotechnology
- Other
- Person Career
- Psychology
- Quotation
- Rockford
- Theresa Pape
- Transcranial magnetic stimulation
- treatment for Parkinson’s disease
- Treatment of bipolar disorder
- US Department of Veterans Affairs
Josh Villa was involved in a late night car accident in 2005. He had a drink with a friend before driving home and ended up mounting the kerb and flipping over. The 26 year old went through the windscreen and was comatosed. 12 months after the crash there was little cause for optimism. “He would open his eyes but he was not responsive to any external stimuli in his environment " noted Theresa Pape of the US Department of Veterans Affairs in Chicago who assisted in his treatment. In most cases there is not much more that can be done for patients in such a condition.
- Read more
- 977 reads
The Long Term Benefits of Good Blood Sugar Control in Type 2 Diabetes.
Submitted by Anonymous on Wed, 2008-09-10 07:57- Blood sugar
- Diabetes
- Diabetes management
- Diabetes mellitus
- Endocrinology
- Glucophage
- head
- http://www.nejm.org
- http://www2.niddk.nih.gov
- Medicine
- Metformin
- New England Journal
- Other
- Rome
- Rury Holman
- the New England Journal of Medicine
- Tolbutamide
- United Kingdom
- University of Oxford
- Vanderbilt University
- Vanderbilt University
The patient with type 2 or adult onset diabetes and who keeps a tight rein on their blood sugar even if they only do so for the first ten years after being diagnosed will have far lower risks of heart attacks and multiple other complications. Followup studies indicate a "legacy effect" which will likely put an emphasis on increasingly "rigorous" treatment of type 2 diabetes when they are first diagnosed. "What you don't want is for people to think that they had a period of good glucose control and then they allow their blood glucose to go high _ that would be disadvantageous " said Dr.
- Read more
- 1018 reads
Conference call 7/21: Vytorin improves cholesterol cardiac outcomes
Submitted by Anonymous on Tue, 2008-07-22 11:52- Aging-associated diseases
- Aortic valve stenosis
- Atherosclerosis
- Biology
- Cardiology
- Cardiovascular diseases
- Chairman
- Duke University
- Duke University
- Ezetimibe
- Ezetimibe/simvastatin
- Harvard University
- Harvard University
- head
- IMPROVE-IT
- Ireland
- Major
- Medicine
- Oslo
- Oxford University
- Oxford University
- Person Career
- Peto
- Politics
- Politics
- Professor
- Scandinavia
- Schering-Plough
- SHARP
- Simvastatin
- simvastatin
- Statins
- Steering Committee Ulleval University Hospital
- Terje R. Pedersen Professor
- United Kingdom
- University of Oxford Clinical Trial Service Unit
- Vytorin
A press release yesterday on the SEAS trial suggests that intensive cholesterol reduction with simvastatin and ezetimibe combination among patients with mild-moderate aortic stenosis (AS) does not reduce the rate of progression of AS but does appear to reduce the risk of coronary artery disease events. The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) trial is a randomized multinational study which determined the effects of intensive lipid (LDL cholesterol) lowering among patients with mild to moderate aortic stenosis.
- Read more
- 949 reads